FDA Inspection 828694 — ImpactLife

ImpactLife — FEI 1470270

The FDA completed an inspection of ImpactLife on May 1, 2013 in Urbana, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 1, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Urbana, IL (United States)

Citations

IDCFRDescription
1220221 CFR 606.170(a)Adverse Reaction - Investigations